000			01546 a2200433 4500
005			20250513204013.0
264		0	_c20000323
008			200003s 0 0 eng d
022			_a0163-2116
024	7		_a10.1023/a:1005444006042 _2doi
040			_aNLM _beng _cNLM
100	1		_aKearney, D J
245	0	0	_aTreatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. _h[electronic resource]
260			_bDigestive diseases and sciences _cFeb 2000
300			_a265-71 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a2-Pyridinylmethylsulfinylbenzimidazoles
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aBismuth _xtherapeutic use
650	0	4	_aClarithromycin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHelicobacter Infections _xdrug therapy
650	0	4	_aHelicobacter pylori
650	0	4	_aHumans
650	0	4	_aLansoprazole
650	0	4	_aMale
650	0	4	_aMetronidazole _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aOmeprazole _xanalogs & derivatives
650	0	4	_aOrganometallic Compounds _xtherapeutic use
650	0	4	_aProton Pump Inhibitors
650	0	4	_aSalicylates _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
700	1		_aBrousal, A
773	0		_tDigestive diseases and sciences _gvol. 45 _gno. 2 _gp. 265-71
856	4	0	_uhttps://doi.org/10.1023/a:1005444006042 _zAvailable from publisher's website
999			_c10665413 _d10665413